SCHEMBL30845773

SCHEMBL30845773

CN1CCN(c2ccc3nc(C(N)=O)cn3c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.51
HRH3 Q9Y5N1 1/20 0.51
CHEK1 O14757 3/20 0.46
PIM1 P11309 2/20 0.46
PIM3 Q86V86 1/20 0.46
KDM4E B2RXH2 3/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ADRA2C P18825 1/20 0.41
GFER P55789 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21033171 0.88 HRH4 (0.52) HRH4HRH3CHEK1KDM4ENPC1
SCHEMBL30845792 0.84 KDM4E (0.53) KDM4EHTTNPC1RAB9ALMNA
SCHEMBL21033293 0.82 KDM4E (0.55) HRH4HRH3KDM4ENPC1RAB9A
SCHEMBL8065354 0.75 TGFBR1 (0.50) HRH4HRH3KDM4ENPC1RAB9A
SCHEMBL21033169 0.74 PTGS1 (0.50) HRH4HRH3KDM4ENPC1RAB9A
SCHEMBL30845741 0.71 EGLN1 (0.52) HRH4HRH3CHEK1PIM1KDM4E
SCHEMBL17512464 0.71 TGFBR1 (0.44) HRH4HRH3KDM4ENPC1RAB9A
SCHEMBL16104299 0.71 CLK1 (0.55) HRH4HRH3KDM4EALDH1A1MAPT
SCHEMBL21033175 0.71 KDM4E (0.54) KDM4ENPC1RAB9ALMNASMN1; SMN2
SCHEMBL21033712 0.71 KDM4E (0.60) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111542523-B Heterocyclic compounds as PRMT5 inhibitors 朱比连特埃皮斯科瑞有限责任公司 2024-03-29 CN claimed
CN-111542523-B Heterocyclic compounds as PRMT5 inhibitors 朱比连特埃皮斯科瑞有限责任公司 2024-03-29 CN disclosed